Interestingly, the MS heterozygotes were younger than MM homozygotes and presented also with significantly worse parameters of liver dysfunction in comparison with MM homozygotes (MELD score, bilirubin, prothrombin time, creatinine) but they did not differ in serum albumin level. This evidence concerns the gene F2 and Decreased liver function.